Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 295
Selected: 0
NCT IDTitle
NCT03030599A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
NCT02091206A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)
NCT04984278Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis
NCT06435429A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
NCT00822094Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)
NCT02073474An Observational Post-Marketing Safety Registry of Sativex®
NCT00594256Sodium Oxybate in Schizophrenia With Insomnia
NCT05826756Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting
NCT04269213CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old
NCT02539823Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans
NCT05485831Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY
NCT05557045A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815
NCT06113237Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy
NCT02660255Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy
NCT04389840Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure
NCT02892123Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers
NCT01143181Study to Assess Brincidofovir Treatment of Serious Diseases or Conditions Caused by Double-stranded DNA Viruses
NCT01606137A Study of the Long-term Safety of Sativex Use
NCT01887301Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients
NCT00901732Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
NCT01323465Study to Evaluate the Effect of Rifampicin, Ketoconazole, and Omeprazole on the Pharmacokinetics of Sativex
NCT07282587Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma
NCT04899947Child and Adolescent Registry for Participants With Narcolepsy
NCT02419469Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
NCT00670696A Study to Compare the Efficacy of Rapydan Versus Tetracaine Gel
NCT07533942A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
NCT03848832Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
NCT02257684A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
NCT07778810Epidiolex Trial for Presymptomatic Treatment of Sturge-Weber Syndrome
NCT04145531An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)
NCT01426295Pharmaco-economic Study of a New Medical Device Performed From the Perspective of the Hospital
NCT01265810Caphosol in Oral Mucositis Due to Targeted Therapy
NCT05169307CPX-351 Real-World Effectiveness and Safety Study
NCT05542407ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
NCT01943682Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma
NCT00702468Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis
NCT04610658Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC
NCT05091567A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer
NCT01610700An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients
NCT00875693A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML)
NCT00598078Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor
NCT03295396ONC201 in Adults With Recurrent H3 K27M-mutant Glioma
NCT04899050Epidiolex in Typical Absence Seizures
NCT03575325Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia
NCT02150928An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase)
NCT02544750An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
NCT01643408A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
NCT03572764CPX-351 (Vyxeos™) for Transplant Eligible, Higher Risk Patients With Myelodysplastic Syndrome
NCT04252586A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
NCT00132873Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy